<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.myelomasolutionsfund.org/wp-content/plugins/epc_sitemap_xml/sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url>
<loc>https://www.myelomasolutionsfund.org/fellowships/msf-computational-biology-fellows/</loc>
<lastmod>2026-07-13</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/who-we-are/</loc>
<lastmod>2026-07-13</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/fellowships/</loc>
<lastmod>2026-07-13</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/deciphering-spatial-determinants-of-immunity-and-outcomes-in-t414-mm/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/msf-announces-their-investment-in-predicta-biosciences/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/investments/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/identification-of-transcriptional-targets-of-nsd2-reveal-novel-molecular-mechanisms-of-the-role-of-nsd2-in-t414-mm/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/</loc>
<lastmod>2026-06-26</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/myeloma-solutions-fund-genomic-core/</loc>
<lastmod>2026-03-18</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/delivering-forever-in-vivo-immunotherapy-factories-with-single-treatment-next-gen-cell-therapies/</loc>
<lastmod>2026-03-18</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/partnerships/</loc>
<lastmod>2026-03-18</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/integrating-multiple-myeloma-projects-to-accelerate-a-cure-for-t414-immpact/</loc>
<lastmod>2026-03-16</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/towards-curative-immunotherapy-t414-myeloma-targeting-persister-stemness-pathways/</loc>
<lastmod>2025-10-13</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/crispr-studies-t414-mm-define-tumor-cell-vulnerabilities-treatment-resistance-mechanisms/</loc>
<lastmod>2025-10-13</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/2024-recipients-of-the-msf-computational-biology-fellowship-program-in-mm/</loc>
<lastmod>2025-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/single-cell-analysis-of-immune-correlates-following-engineered-nk-cell-therapy-in-myeloma/</loc>
<lastmod>2025-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/deciphering-spatial-architecture-bone-marrow-microenvironment-multiple-myeloma-to-achieve-granular-insights-into-outcomes/</loc>
<lastmod>2025-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/targeting-swi-snf-t414-multiple-myeloma/</loc>
<lastmod>2024-09-23</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/msf-announces-their-investment-in-slingshot-biosciences/</loc>
<lastmod>2024-07-02</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/connect-with-us/</loc>
<lastmod>2024-07-02</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/validating-novel-biologic-mediators-therapeutic-targets-t414-myeloma/</loc>
<lastmod>2024-07-02</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/discovering-new-biology-vulnerabilities-in-high-risk-disease-mmrf-commpass-study/</loc>
<lastmod>2024-07-02</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/msf-expands-computational-biology-fellowship-program-in-multiple-myeloma/</loc>
<lastmod>2024-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/expression-of-cd70-is-elevated-in-t414-multiple-myeloma-and-is-a-potential-target-for-immunotherapy/</loc>
<lastmod>2024-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/collaboration-leads-to-first-individual-risk-prediction-model-for-multiple-myeloma/</loc>
<lastmod>2024-02-19</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/the-unmet-medical-need-for-t414-myeloma/</loc>
<lastmod>2024-02-16</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/computational-biology-fellowships-post-doc-program-in-multiple-myeloma/</loc>
<lastmod>2024-02-16</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/news/msf-investment-in-ai-proteins/</loc>
<lastmod>2024-02-16</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/multi-level-immuno-genomic-analyses-to-enhance-patient-specific-therapeutic-decisions-in-high-risk-myeloma/</loc>
<lastmod>2023-09-07</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/grants/targeting-therapy-to-nsd2-the-oncogene-deregulated-by-t414-in-multiple-myeloma/</loc>
<lastmod>2023-08-29</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
<url>
<loc>https://www.myelomasolutionsfund.org/updates/</loc>
<lastmod>2023-07-17</lastmod>
<changefreq>monthly</changefreq>
<priority>1</priority>
</url>
</urlset>